Følg
Lidia Strigari
Lidia Strigari
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy
Verifisert e-postadresse på aosp.bo.it
Tittel
Sitert av
Sitert av
År
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
G Arcangeli, B Saracino, S Gomellini, MG Petrongari, S Arcangeli, ...
International Journal of Radiation Oncology* Biology* Physics 78 (1), 11-18, 2010
3192010
Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations
L Strigari, R Sciuto, S Rea, L Carpanese, G Pizzi, A Soriani, G Iaccarino, ...
Journal of Nuclear Medicine 51 (9), 1377-1385, 2010
2832010
The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
L Strigari, M Konijnenberg, C Chiesa, M Bardies, Y Du, KS Gleisner, ...
European journal of nuclear medicine and molecular imaging 41, 1976-1988, 2014
2422014
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer
S Arcangeli, L Strigari, S Gomellini, B Saracino, MG Petrongari, P Pinnarò, ...
International Journal of Radiation Oncology* Biology* Physics 84 (5), 1172-1178, 2012
2292012
Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19
M Watanabe, D Caruso, D Tuccinardi, R Risi, M Zerunian, M Polici, ...
Metabolism 111, 154319, 2020
2072020
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective
M Cremonesi, C Chiesa, L Strigari, M Ferrari, F Botta, F Guerriero, ...
Frontiers in oncology 4, 210, 2014
2032014
Diffusion-weighted MR imaging in the evaluation of renal tumours
E Squillaci, G Manenti, F Di Stefano, R Miano, L Strigari, G Simonetti
Journal of Experimental and Clinical Cancer Research 23 (1), 39-46, 2004
1932004
Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer
G Arcangeli, J Fowler, S Gomellini, S Arcangeli, B Saracino, ...
International Journal of Radiation Oncology* Biology* Physics 79 (4), 1013-1021, 2011
1882011
Moderate hypofractionation in high-risk, organ-confined prostate cancer: final results of a phase III randomized trial
G Arcangeli, B Saracino, S Arcangeli, S Gomellini, MG Petrongari, ...
Journal of Clinical Oncology 35 (17), 1891-1897, 2017
1712017
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases
H Hänscheid, C Canzi, W Eschner, G Flux, M Luster, L Strigari, ...
European journal of nuclear medicine and molecular imaging 40, 1126-1134, 2013
1682013
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
H Levillain, O Bagni, CM Deroose, A Dieudonné, S Gnesin, OS Grosser, ...
European journal of nuclear medicine and molecular imaging 48, 1570-1584, 2021
1592021
Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer
V Bruzzaniti, A Abate, P Pinnarò, M D’Andrea, E Infusino, V Landoni, ...
Journal of Experimental & Clinical Cancer Research 32, 1-7, 2013
1382013
Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
S Nanni, V Benvenuti, A Grasselli, C Priolo, A Aiello, S Mattiussi, ...
The Journal of clinical investigation 119 (5), 1093-1108, 2009
1342009
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials
G Arcangeli, L Strigari, S Arcangeli
Critical reviews in oncology/hematology 95 (3), 387-396, 2015
1312015
Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
M Cremonesi, ME Ferrari, L Bodei, C Chiesa, A Sarnelli, C Garibaldi, ...
European journal of nuclear medicine and molecular imaging 45, 2426-2441, 2018
1202018
A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?
R Marconi, S Strolin, G Bossi, L Strigari
PloS one 12 (2), e0171559, 2017
1142017
Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors
F Guerriero, ME Ferrari, F Botta, F Fioroni, E Grassi, A Versari, A Sarnelli, ...
BioMed research international 2013, 2013
1052013
Very-low-calorie ketogenic diets with whey, vegetable, or animal protein in patients with obesity: a randomized pilot study
S Basciani, E Camajani, S Contini, A Persichetti, R Risi, L Bertoldi, ...
The Journal of Clinical Endocrinology & Metabolism 105 (9), 2939-2949, 2020
982020
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
A Botticelli, CE Onesti, I Zizzari, B Cerbelli, P Sciattella, M Occhipinti, ...
Oncotarget 8 (59), 99336, 2017
922017
The Top-Implart Project
C Ronsivalle, M Carpanese, C Marino, G Messina, L Picardi, S Sandri, ...
The European Physical Journal Plus 126, 1-15, 2011
912011
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20